TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee

Ads

You May Also Like

NANOBIOTIX : 2016 review and 2017 anticipated milestones

   Nanobiotix: 2016 review and 2017 anticipated milestones Paris, France and Cambridge, Massachusetts, USA, January ...

Idera Pharmaceuticals Provides 2018 Update and Outlook

EXTON, Pa. and CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ...